[Neurogenic symptoms for the early diagnosis of adverse drug effects].
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D002738:Chloroquine / Q000009:adverse effects; D003348:Cortisone / Q000009:adverse effects; D003863:Depression / Q000139:chemically induced; D064420:Drug-Related Side Effects and Adverse Reactions; D005938:Glucocorticoids / Q000009:adverse effects; D006406:Hematoma / Q000139:chemically induced; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced; D008750:Methyldopa / Q000009:adverse effects; D009133:Muscular Atrophy / Q000139:chemically induced; D009422:Nervous System Diseases / Q000139:chemically induced; D009461:Neurologic Manifestations; D009469:Neuromuscular Junction / Q000187:drug effects; D010243:Paralysis / Q000139:chemically induced; D011041:Poisoning / Q000175:diagnosis*; D046948:Secologanin Tryptamine Alkaloids / Q000009:adverse effects; D013117:Spinal Cord Compression / Q000209:etiology; D014149:Tranquilizing Agents / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D005938:Glucocorticoids; D046948:Secologanin Tryptamine Alkaloids; D014149:Tranquilizing Agents; D008750:Methyldopa; D002738:Chloroquine; D003348:Cortisone
Neurogene Symptome zur Frühdiagnose unerwünschter Arzneimittelwirkungen.